Lupuzor phase 3 to start

New Topic Post Reply Printable Version
[ << Previous Thread | Next Thread >> ]

waterloo01
New Member


Date Joined Oct 2013
Total Posts : 10
   Posted 1/22/2015 3:43 AM (GMT -6)   
The clinical study is titled "A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus". It is a pivotal study designed to demonstrate the safety and efficacy of IPP-201101 and as a last step prior to the filing of the drug for approval with the US Food & Drug Administration ("FDA") and the European Medicines Agency ("EMA").

http://www.immupharma.org/regulatory-news
New Topic Post Reply Printable Version
Forum Information
Currently it is Monday, June 25, 2018 3:32 AM (GMT -6)
There are a total of 2,974,910 posts in 326,222 threads.
View Active Threads


Who's Online
This forum has 161315 registered members. Please welcome our newest member, Noluck.
281 Guest(s), 1 Registered Member(s) are currently online.  Details
Noluck